Annual Review of Cancer Biology

Papers
(The H4-Index of Annual Review of Cancer Biology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Telomeres and Cancer: Resolving the Paradox42
Reinventing Radiobiology in the Light of FLASH Radiotherapy38
The Bidirectional Relationship Between Cancer Epigenetics and Metabolism36
Targeting Solid Tumors with Bispecific T Cell Engager Immune Therapy33
Humanized Mouse Models to Evaluate Cancer Immunotherapeutics32
Immunometabolism in the Tumor Microenvironment31
The Multifaceted Role of Regulatory T Cells in Breast Cancer30
Small-Molecule Approaches to Targeted Protein Degradation30
Myeloid-Derived Suppressor Cells: Facilitators of Cancer and Obesity-Induced Cancer19
Central Role of the Antigen-Presentation and Interferon-γ Pathways in Resistance to Immune Checkpoint Blockade19
Targeting KRAS G12C with Covalent Inhibitors18
Personal Neoantigen Vaccines for the Treatment of Cancer17
Oncohistones: Hijacking the Histone Code16
Nutritional Preconditioning in Cancer Treatment in Relation to DNA Damage and Aging15
Reeling in the Zebrafish Cancer Models15
0.02541184425354